ADARs: Allies or enemies? The importance of A-to-I RNA editing in human disease: From cancer to HIV-1

Biological Reviews

Volumn 87, Issue 1, 2012, Pages 95-110

  Gallo, Angela ^a   Locatelli, Franco ^a,b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

ADARs; ALS; Cancer; Diabetes; DSH; HIV 1; Ischaemia; MicroRNA; Prader Willi syndrome; RNA editing; SLE

Indexed keywords

ADENOSINE DEAMINASE; DSRNA ADENOSINE DEAMINASE;

ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW; RNA EDITING; VIROLOGY;

ADENOSINE DEAMINASE; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIV INFECTIONS; HIV-1; HUMANS; NEOPLASMS; RNA EDITING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 84855255195     PISSN: 14647931     EISSN: 1469185X     Source Type: Journal    
DOI: 10.1111/j.1469-185X.2011.00186.x     Document Type: Review

References (162)

1. Agranat, L., Sperling, J. & Sperling, R. (2010). A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2. RNA Biology 7, 253-62.
2. Ahmed, M., Taylor, W., Smith, P. R. & Becker, M. A. (1999). Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase. Journal of Biological Chemistry 274, 7482-8.
3. Aizawa, H., Sawada, J., Hideyama, T., Yamashita, T., Katayama, T., Hasebe, N., Kimura, T., Yahara, O. & Kwak, S. (2010). TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathologica 120, 75-84.
4. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-97.
5. Basilio, C., Wahba, A. J., Lengyel, P., Speyer, J. F. & Ochoa, S. (1962). Synthetic polynucleotides and the amino acid code. V. Proceedings of the National Accademy of Science U S A 48, 613-6.
6. Bass, B. L. (2002). RNA editing by adenosine deaminases that act on RNA. Annual Review of Biochemistry 71, 817-46.
7. Bass, B. L. & Weintraub, H. (1987). A developmentally regulated activity that unwinds RNA duplexes. Cell 48, 607-13.
8. Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R. & Stark, G. R. (2007). Interferons at age 50: past, current and future impact on biomedicine. Nature Reviews Drug Discovery 6, 975-90.
9. Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E. & Emeson, R. B. (1997). Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387, 303-8.
10. Carlezon, W. A., JR., Duman, R. S. & Nestler, E. J. (2005). The many faces of CREB. Trends in Neurosciences 28, 436-45.
11. Cavaille, J., Buiting, K., Kiefmann, M., Lalande, M., Brannan, C. I., Horsthemke, B., Bachellerie, J. P., Brosius, J. & Huttenhofer, A. (2000). Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proceedings of the National Accademy of Science U S A 97, 14311-6.
12. Cenci, C., Barzotti, R., Galeano, F., Corbelli, S., Rota, R., Massimi, L., Di Rocco, C., O'Connell, M. A. & Gallo, A. (2008). Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. Journal of Biological Chemistry 283, 7251-60.
13. Chatterjee, S. & Pal, J. K. (2009). Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biology of the Cell 101, 251-62.
14. Chen, C. X., Cho, D. S., Wang, Q., Lai, F., Carter, K. C. & Nishikura, K. (2000). A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. Rna 6, 755-67.
15. Chilibeck, K. A., Wu, T., Liang, C., Schellenberg, M. J., Gesner, E. M., Lynch, J. M. & MacMillan, A. M. (2006). FRET analysis of in vivo dimerization by RNA-editing enzymes. Journal of Biological Chemistry 281, 16530-5.
16. Cho, D. S., Yang, W., Lee, J. T., Shiekhattar, R., Murray, J. M. & Nishikura, K. (2003). Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA. Journal of Biological Chemistry 278, 17093-102.
17. Clerzius, G., Gelinas, J. F., Daher, A., Bonnet, M., Meurs, E. F. & Gatignol, A. (2009). ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication. Journal of Virology 83, 10119-28.
18. Connolly, C. M., Dearth, A. T. & Braun, R. E. (2005). Disruption of murine Tenr results in teratospermia and male infertility. Developmental Biology 278, 13-21.
19. Couper, R. (1999). Prader-Willi syndrome. Journal Paediatric Child Health 35, 331-4.
20. Daniel, C. & Ohman, M. (2009). RNA editing and its impact on GABAA receptor function. Biochemical Society Transactions 37, 1399-403.
21. de Hoon, M. J., Taft, R. J., Hashimoto, T., Kanamori-Katayama, M., Kawaji, H., Kawano, M., Kishima, M., Lassmann, T., Faulkner, G. J., Mattick, J. S., Daub, C. O., Carninci, P., Kawai, J., Suzuki, H. & Hayashizaki, Y. (2010). Cross-mapping and the identification of editing sites in mature microRNAs in high-throughput sequencing libraries. Genome Research 20, 257-64.
22. DeCerbo, J. & Carmichael, G. G. (2005). Retention and repression: fates of hyperedited RNAs in the nucleus. Current Opinion Cell Biology 17, 302-8.
23. Desterro, J. M., Keegan, L. P., Jaffray, E., Hay, R. T., O'Connell, M. A. & Carmo-Fonseca, M. (2005). SUMO-1 modification alters ADAR1 editing activity. Molecular Biology of the Cell 16, 5115-26.
24. Desterro, J. M., Keegan, L. P., Lafarga, M., Berciano, M. T., O'Connell, M. & Carmo-Fonseca, M. (2003). Dynamic association of RNA-editing enzymes with the nucleolus. Journal of the Cell Science 116, 1805-18.
25. Doria, M., Neri, F., Gallo, A., Farace, M. G. & Michienzi, A. (2009). Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Research 37, 5848-58.
26. Doria, M., Tomaselli, S., Neri, F., Ciafre, S. A., Farace, M. G., Michienzi, A. & Gallo, A. (2011). The ADAR2 Editing Enzyme Is A Novel Hiv-1 Proviral Factor. Journal of General Virology 92, 1228-32.
27. Eckmann, C. R., Neunteufl, A., Pfaffstetter, L. & Jantsch, M. F. (2001). The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein. Molecular Biology of the Cell 12, 1911-24.
28. Enstero, M., Akerborg, O., Lundin, D., Wang, B., Furey, T. S., Ohman, M. & Lagergren, J. (2010). A computational screen for site selective A-to-I editing detects novel sites in neuron specific Hu proteins. BMC Bioinformatics 11, 6.
29. Feng, Y., Sansam, C. L., Singh, M. & Emeson, R. B. (2006). Altered RNA editing in mice lacking ADAR2 autoregulation. Molecular and Cellular Biology 26, 480-8.
30. Flanagan, J. M., Funes, J. M., Henderson, S., Wild, L., Carey, N. & Boshoff, C. (2009). Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. Mol Cancer Therapeutics 8, 249-60.
31. Fritz, J., Strehblow, A., Taschner, A., Schopoff, S., Pasierbek, P. & Jantsch, M. F. (2009). RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1. Molecular and Cellular Biology 29, 1487-97.
32. Galeano, F., Leroy, A., Rossetti, C., Gromova, I., Gautier, P., Keegan, L. P., Massimi, L., Di Rocco, C., O'Connell, M. A. & Gallo, A. (2010). Human BLCAP transcript: new editing events in normal and cancerous tissues. International Journal of Cancer 127, 127-37.
33. Gallo, A. & Galardi, S. (2008). A-to-I RNA editing and cancer: From pathology to basic science. RNA Biology 5, 135-139.
34. Gallo, A., Keegan, L. P., Ring, G. M. & O'Connell, M. A. (2003). An ADAR that edits transcripts encoding ion channel subunits functions as a dimer. EMBO Journal 22, 3421-30.
35. Gan, Z., Zhao, L., Yang, L., Huang, P., Zhao, F., Li, W. & Liu, Y. (2006). RNA editing by ADAR2 is metabolically regulated in pancreatic islets and beta-cells. Journal of Biological Chemistry 281, 33386-94.
36. George, C. X., Das, S. & Samuel, C. E. (2008). Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5′-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon. Virology 380, 338-43.
37. George, C. X. & Samuel, C. E. (1999a). Characterization of the 5′-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene 229, 203-13.
38. George, C. X. & Samuel, C. E. (1999b). Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proceedings of the National Accademy of Science U S A 96, 4621-6.
39. George, C. X., Wagner, M. V. & Samuel, C. E. (2005). Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing. Journal of Biological Chemistry 280, 15020-8.
40. Gerber, A., O'Connell, M. A. & Keller, W. (1997). Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. Rna 3, 453-63.
41. Gorter, J. A., Petrozzino, J. J., Aronica, E. M., Rosenbaum, D. M., Opitz, T., Bennett, M. V., Connor, J. A. & Zukin, R. S. (1997). Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. Journal of Neuroscience 17, 6179-88.
42. Gott, J. M. & Emeson, R. B. (2000). Functions and mechanisms of RNA editing. Annual Review of Genetics 34, 499-531.
43. Greenberger, S., Levanon, E. Y., Paz-Yaacov, N., Barzilai, A., Safran, M., Osenberg, S., Amariglio, N., Rechavi, G. & Eisenberg, E. (2010). Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats. BMC Genomics 11, 608.
44. Habig, J. W., Dale, T. & Bass, B. L. (2007). miRNA editing-we should have inosine this coming. Molecular Cell 25, 792-3.
45. Hanna, G. L., Veenstra-Vanderweele, J., Cox, N. J., Van Etten, M., Fischer, D. J., Himle, J. A., Bivens, N. C., Wu, X., Roe, C. A., Hennessy, K. A., Dickel, D. E., Leventhal, B. L. & Cook, E. H., JR. (2007). Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder. Biological Psychiatry 62, 856-62.
46. Hartner, J. C., Schmittwolf, C., Kispert, A., Muller, A. M., Higuchi, M. & Seeburg, P. H. (2004). Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. Journal of Biological Chemistry 279, 4894-902.
47. Hartner, J. C., Walkley, C. R., Lu, J. & Orkin, S. H. (2009). ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nature Immunology 10, 109-15.
48. Heale, B. S., Keegan, L. P., McGurk, L., Michlewski, G., Brindle, J., Stanton, C. M., Caceres, J. F. & O'Connell, M. A. (2009). Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO Journal 28, 3145-56.
49. Herbert, A., Alfken, J., Kim, Y. G., Mian, I. S., Nishikura, K. & Rich, A. (1997). A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. Proceedings of the National Accademy of Science U S A 94, 8421-6.
50. Herbert, A. & Rich, A. (1999). Left-handed Z-DNA: structure and function. Genetica 106, 37-47.
51. Herbert, A. & Rich, A. (2001). The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1. Proceedings of the National Accademy of Science U S A 98, 12132-7.
52. Hideyama, T., Yamashita, T., Suzuki, T., Tsuji, S., Higuchi, M., Seeburg, P. H., Takahashi, R., Misawa, H. & Kwak, S. (2010). Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2. Journal of Neuroscince 30, 11917-25.
53. Higuchi, M., Maas, S., Single, F. N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R. & Seeburg, P. H. (2000). Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406, 78-81.
54. Higuchi, M., Single, F. N., Kohler, M., Sommer, B., Sprengel, R. & Seeburg, P. H. (1993). RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75, 1361-70.
55. Hoopengardner, B., Bhalla, T., Staber, C. & Reenan, R. (2003). Nervous system targets of RNA editing identified by comparative genomics. Science 301, 832-6.
56. Hough, R. F. & Bass, B. L. (1997). Analysis of Xenopus dsRNA adenosine deaminase cDNAs reveals similarities to DNA methyltransferases. Rna 3, 356-70.
57. Ishiuchi, S., Tsuzuki, K., Yoshida, Y., Yamada, N., Hagimura, N., Okado, H., Miwa, A., Kurihara, H., Nakazato, Y., Tamura, M., Sasaki, T. & Ozawa, S. (2002). Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nature Medicine 8, 971-8.
58. Jaikaran, D. C., Collins, C. H. & MacMillan, A. M. (2002). Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site. Journal of Biological Chemistry 277, 37624-9.
59. Jin, Y., Zhang, W. & Li, Q. (2009). Origins and evolution of ADAR-mediated RNA editing. IUBMB Life 61, 572-8.
60. Kawahara, Y., Ito, K., Sun, H., Aizawa, H., Kanazawa, I. & Kwak, S. (2004a). Glutamate receptors: RNA editing and death of motor neurons. Nature 427, 801.
61. Kawahara, Y., Ito, K., Sun, H., Ito, M., Kanazawa, I. & Kwak, S. (2004b). Regulation of glutamate receptor RNA editing and ADAR mRNA expression in developing human normal and Down's syndrome brains. Developmental Brain Research 148, 151-5.
62. Kawahara, Y. & Kwak, S. (2005). Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons? Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 6, 131-44.
63. Kawahara, Y., Zinshteyn, B., Sethupathy, P., Iizasa, H., Hatzigeorgiou, A. G. & Nishikura, K. (2007). Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315, 1137-40.
64. Kawakubo, K. & Samuel, C. E. (2000). Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene 258, 165-72.
65. Keegan, L. P., Gallo, A. & O'Connell, M. A. (2001). The many roles of an RNA editor. Nature Reviews Genetics 2, 869-78.
66. Kim, U., Garner, T. L., Sanford, T., Speicher, D., Murray, J. M. & Nishikura, K. (1994a). Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. Journal of Biological Chemistry 269, 13480-9.
67. Kim, U., Wang, Y., Sanford, T., Zeng, Y. & Nishikura, K. (1994b). Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proceedings of the National Accademy of Science U S A 91, 11457-61.
68. Kiran, A. & Baranov, P. V. (2010). DARNED: a DAtabase of RNa EDiting in humans. Bioinformatics 26, 1772-6.
69. Kleihues, P., Burger, P. C. & Scheithauer, B. W. (1993). The new WHO classification of brain tumours. Brain Pathology 3, 255-68.
70. Kozora, E., Thompson, L. L., West, S. G. & Kotzin, B. L. (1996). Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis and Rheumatism 39, 2035-45.
71. Kuner, R., Groom, A. J., Bresink, I., Kornau, H. C., Stefovska, V., Muller, G., Hartmann, B., Tschauner, K., Waibel, S., Ludolph, A. C., Ikonomidou, C., Seeburg, P. H. & Turski, L. (2005). Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proceedings of the National Accademy of Science U S A 102, 5826-31.
72. Kwak, S. & Kawahara, Y. (2005). Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. Journal of Molecular Medicine 83, 110-20.
73. Lai, F., Chen, C. X., Carter, K. C. & Nishikura, K. (1997). Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases. Molecular and Cellular Biology 17, 2413-24.
74. Laxminarayana, D., O'Rourke, K. S., Maas, S. & Olorenshaw, I. (2007). Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes. Immunology 121, 359-69.
75. Lee, R. C., Feinbaum, R. L. & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-54.
76. Lei, M., Liu, Y. & Samuel, C. E. (1998). Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase. Virology 245, 188-96.
77. Levanon, E. Y., Eisenberg, E., Yelin, R., Nemzer, S., Hallegger, M., Shemesh, R., Fligelman, Z. Y., Shoshan, A., Pollock, S. R., Sztybel, D., Olshansky, M., Rechavi, G. & Jantsch, M. F. (2004). Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nature Biotechnology 22, 1001-5.
78. Levanon, E. Y., Hallegger, M., Kinar, Y., Shemesh, R., Djinovic-Carugo, K., Rechavi, G., Jantsch, M. F. & Eisenberg, E. (2005). Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Research 33, 1162-8.
79. Li, J. B., Levanon, E. Y., Yoon, J. K., Aach, J., Xie, B., Leproust, E., Zhang, K., Gao, Y. & Church, G. M. (2009). Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 324, 1210-3.
80. Liu, Q., Jiang, L., Liu, W. L., Kang, X. J., Ao, Y., Sun, M., Luo, Y., Song, Y., Lo, W. H. & Zhang, X. (2006). Two novel mutations and evidence for haploinsufficiency of the ADAR gene in dyschromatosis symmetrica hereditaria. The British journal of Dermatology 154, 636-42.
81. Liu, Y., George, C. X., Patterson, J. B. & Samuel, C. E. (1997). Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. Journal of Biological Chemistry 272, 4419-28.
82. Liu, Y., Wolff, K. C., Jacobs, B. L. & Samuel, C. E. (2001). Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. Virology 289, 378-87.
83. Lykke-Andersen, S., Pinol-Roma, S. & Kjems, J. (2007). Alternative splicing of the ADAR1 transcript in a region that functions either as a 5′-UTR or an ORF. Rna 13, 1732-44.
84. Maas, S. & Gommans, W. M. (2009a). Identification of a selective nuclear import signal in adenosine deaminases acting on RNA. Nucleic Acids Research 37, 5822-9.
85. Maas, S. & Gommans, W. M. (2009b). Novel exon of mammalian ADAR2 extends open reading frame. PLoS One 4, e4225.
86. Maas, S., Patt, S., Schrey, M. & Rich, A. (2001). Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proceedings of the National Accademy of Science U S A 98, 14687-92.
87. Macbeth, M. R., Schubert, H. L., Vandemark, A. P., Lingam, A. T., Hill, C. P. & Bass, B. L. (2005). Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 309, 1534-9.
88. Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K. & DePinho, R. A. (2001). Malignant glioma: genetics and biology of a grave matter. Genes & Development 15, 1311-33.
89. Melcher, T., Maas, S., Herb, A., Sprengel, R., Higuchi, M. & Seeburg, P. H. (1996a). RED2, a brain-specific member of the RNA-specific adenosine deaminase family. Journal of Biological Chemistry 271, 31795-8.
90. Melcher, T., Maas, S., Herb, A., Sprengel, R., Seeburg, P. H. & Higuchi, M. (1996b). A mammalian RNA editing enzyme. Nature 379, 460-4.
91. Meyer, O. (2009). Interferons and autoimmune disorders. Joint Bone Spine 76, 464-73.
92. Mignone, F., Gissi, C., Liuni, S. & Pesole, G. (2002). Untranslated regions of mRNAs. Genome Biology 3.
93. Mittaz, L., Antonarakis, S. E., Higuchi, M. & Scott, H. S. (1997a). Localization of a novel human RNA-editing deaminase (hRED2 or ADARB2) to chromosome 10p15. Human Genetics 100, 398-400.
94. Mittaz, L., Scott, H. S., Rossier, C., Seeburg, P. H., Higuchi, M. & Antonarakis, S. E. (1997b). Cloning of a human RNA editing deaminase (ADARB1) of glutamate receptors that maps to chromosome 21q22.3. Genomics 41, 210-7.
95. Miyamura, Y., Suzuki, T., Kono, M., Inagaki, K., Ito, S., Suzuki, N. & Tomita, Y. (2003). Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. American Journal of Human Genetics 73, 693-9.
96. Morabito, M. V., Abbas, A. I., Hood, J. L., Kesterson, R. A., Jacobs, M. M., Kump, D. S., Hachey, D. L., Roth, B. L. & Emeson, R. B. (2010). Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiology of Disease 39, 169-80.
97. Morita, E. & Sundquist, W. I. (2004). Retrovirus budding. Annual Review Cell and Developmental Biology 20, 395-425.
98. Morse, D. P., Aruscavage, P. J. & Bass, B. L. (2002). RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA. Proceedings of the National Accademy of Science U S A 99, 7906-11.
99. Morse, D. P. & Bass, B. L. (1997). Detection of inosine in messenger RNA by inosine-specific cleavage. Biochemistry 36, 8429-34.
100. Nie, Y., Ding, L., Kao, P. N., Braun, R. & Yang, J. H. (2005). ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Molecular and Cellular Biology 25, 6956-63.
101. Nie, Y., Hammond, G. L. & Yang, J. H. (2007). Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. Journal of Virology 81, 917-23.
102. Nie, Y., Zhao, Q., Su, Y. & Yang, J. H. (2004). Subcellular distribution of ADAR1 isoforms is synergistically determined by three nuclear discrimination signals and a regulatory motif. Journal of Biological Chemistry 279, 13249-55.
103. Nishikura, K. (2006). Editor meets silencer: crosstalk between RNA editing and RNA interference. Nature Reviews Molecular and Cellular Biology 7, 919-31.
104. Nishikura, K. (2010). Functions and regulation of RNA editing by ADAR deaminases. Annual Review of Biochemistry 79, 321-49.
105. O'Connell, M. A., Gerber, A. & Keller, W. (1997). Purification of human double-stranded RNA-specific editase 1 (hRED1) involved in editing of brain glutamate receptor B pre-mRNA. Journal of Biological Chemistry 272, 473-8.
106. O'Connell, M. A. & Keller, W. (1994). Purification and properties of double-stranded RNA-specific adenosine deaminase from calf thymus. Proceedings of the National Accademy of Science U S A 91, 10596-600.
107. O'Connell, M. A., Krause, S., Higuchi, M., Hsuan, J. J., Totty, N. F., Jenny, A. & Keller, W. (1995). Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Molecular and Cellular Biology 15, 1389-97.
108. Ohlson, J., Pedersen, J. S., Haussler, D. & Ohman, M. (2007). Editing modifies the GABA(A) receptor subunit alpha3. Rna 13, 698-703.
109. Orlowski, R. J., O'Rourke, K. S., Olorenshaw, I., Hawkins, G. A., Maas, S. & Laxminarayana, D. (2008). Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytes. Immunology 125, 408-19.
110. Patterson, J. B. & Samuel, C. E. (1995). Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Molecular and Cellular Biology 15, 5376-88.
111. Paz, N., Levanon, E. Y., Amariglio, N., Heimberger, A. B., Ram, Z., Constantini, S., Barbash, Z. S., Adamsky, K., Safran, M., Hirschberg, A., Krupsky, M., Ben-Dov, I., Cazacu, S., Mikkelsen, T., Brodie, C., Eisenberg, E. & Rechavi, G. (2007). Altered adenosine-to-inosine RNA editing in human cancer. Genome Research 17, 1586-95.
112. Peng, P. L., Zhong, X., Tu, W., Soundarapandian, M. M., Molner, P., Zhu, D., Lau, L., Liu, S., Liu, F. & Lu, Y. (2006). ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron 49, 719-33.
113. Phuphuakrat, A., Kraiwong, R., Boonarkart, C., Lauhakirti, D., Lee, T. H. & Auewarakul, P. (2008). Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. Journal of Viorology 82, 10864-72.
114. Porte, D., JR. & Kahn, S. E. (2001). beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 50 Suppl 1, S160-3.
115. Poulsen, H., Jorgensen, R., Heding, A., Nielsen, F. C., Bonven, B. & Egebjerg, J. (2006). Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. Rna 12, 1350-60.
116. Poulsen, H., Nilsson, J., Damgaard, C. K., Egebjerg, J. & Kjems, J. (2001). CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Molecular and Cellular Biology 21, 7862-71.
117. Rebagliati, M. R. & Melton, D. A. (1987). Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 48, 599-605.
118. Reddy, S., Dolzhanskaya, N., Krogh, J. & Velinov, M. (2009). A novel 1.4 Mb de novo microdeletion of chromosome 1q21.3 in a child with microcephaly, dysmorphic features and mental retardation. European Journal of Medical Genetics 52, 443-5.
119. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H. X. & etal (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
120. Rueter, S. M., Dawson, T. R. & Emeson, R. B. (1999). Regulation of alternative splicing by RNA editing. Nature 399, 75-80.
121. Rula, E. Y. & Emeson, R. B. (2007). Mouse models to elucidate the functional roles of adenosine-to-inosine editing. Methods in Enzymology 424, 333-67.
122. Ryter, J. M. & Schultz, S. C. (1998). Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA. EMBO Journal 17, 7505-13.
123. Samuel, C. E. (2001). Antiviral actions of interferons. Clinical Microbiology Reviews 14, 778-809, table of contents.
124. Scadden, A. D. (2005). The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nature Structural & Molecular Biology 12, 489-96.
125. Schade, M., Behlke, J., Lowenhaupt, K., Herbert, A., Rich, A. & Oschkinat, H. (1999a). A 6 bp Z-DNA hairpin binds two Z alpha domains from the human RNA editing enzyme ADAR1. FEBS Letters 458, 27-31.
126. Schade, M., Turner, C. J., Kuhne, R., Schmieder, P., Lowenhaupt, K., Herbert, A., Rich, A. & Oschkinat, H. (1999b). The solution structure of the Zalpha domain of the human RNA editing enzyme ADAR1 reveals a prepositioned binding surface for Z-DNA. Proceedings of the National Accademy of Science U S A 96, 12465-70.
127. Schade, M., Turner, C. J., Lowenhaupt, K., Rich, A. & Herbert, A. (1999c). Structure-function analysis of the Z-DNA-binding domain Zalpha of dsRNA adenosine deaminase type I reveals similarity to the (alpha + beta) family of helix-turn-helix proteins. EMBO Journal 18, 470-9.
128. Schulte, J. H., Marschall, T., Martin, M., Rosenstiel, P., Mestdagh, P., Schlierf, S., Thor, T., Vandesompele, J., Eggert, A., Schreiber, S., Rahmann, S. & Schramm, A. (2010). Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic Acids Research 38, 5919-5928.
129. Schumacher, J. M., Lee, K., Edelhoff, S. & Braun, R. E. (1995). Distribution of Tenr, an RNA-binding protein, in a lattice-like network within the spermatid nucleus in the mouse. Biology of Reproduction 52, 1274-83.
130. Sebastiani, P., Montano, M., Puca, A., Solovieff, N., Kojima, T., Wang, M. C., Melista, E., Meltzer, M., Fischer, S. E., Andersen, S., Hartley, S. H., Sedgewick, A., Arai, Y., Bergman, A., Barzilai, N., Terry, D. F., Riva, A., Anselmi, C. V., Malovini, A., Kitamoto, A., Sawabe, M., Arai, T., Gondo, Y., Steinberg, M. H., Hirose, N., Atzmon, G., Ruvkun, G., Baldwin, C. T. & Perls, T. T. (2009). RNA editing genes associated with extreme old age in humans and with lifespan in C. elegans. PLoS One 4, e8210.
131. Seeburg, P. H. (1993). The TINS/TiPS Lecture. The molecular biology of mammalian glutamate receptor channels. Trends in Neurosciences 16, 359-65.
132. Seeburg, P. H. (2002). A-to-I editing: new and old sites, functions and speculations. Neuron 35, 17-20.
133. Seeburg, P. H., Higuchi, M. & Sprengel, R. (1998). RNA editing of brain glutamate receptor channels: mechanism and physiology. Brain Research Reviews 26, 217-29.
134. Seeburg, P. H., Single, F., Kuner, T., Higuchi, M. & Sprengel, R. (2001). Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse. Brain Research 907, 233-43.
135. Sertie, A. L., Quimby, M., Moreira, E. S., Murray, J., Zatz, M., Antonarakis, S. E. & Passos-Bueno, M. R. (1996). A gene which causes severe ocular alterations and occipital encephalocele (Knobloch syndrome) is mapped to 21q22.3. Human Molecular Genetics 5, 843-7.
136. Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., Steidl, C., Holt, R. A., Jones, S., Sun, M., Leung, G., Moore, R., Severson, T., Taylor, G. A., Teschendorff, A. E., Tse, K., Turashvili, G., Varhol, R., Warren, R. L., Watson, P., Zhao, Y., Caldas, C., Huntsman, D., Hirst, M., Marra, M. A. & Aparicio, S. (2009). Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809-13.
137. Singh, M., Kesterson, R. A., Jacobs, M. M., Joers, J. M., Gore, J. C. & Emeson, R. B. (2007). Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. Journal of Biological Chemistry 282, 22448-59.
138. Slavov, D. & Gardiner, K. (2002). Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns. Gene 299, 83-94.
139. Sommer, B., Kohler, M., Sprengel, R. & Seeburg, P. H. (1991). RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67, 11-9.
140. Stefl, R., Oberstrass, F. C., Hood, J. L., Jourdan, M., Zimmermann, M., Skrisovska, L., Maris, C., Peng, L., Hofr, C., Emeson, R. B. & Allain, F. H. (2010). The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell 143, 225-37.
141. Stefl, R., Xu, M., Skrisovska, L., Emeson, R. B. & Allain, F. H. (2006). Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs. Structure 14, 345-55.
142. Straub, R. E., Lehner, T., Luo, Y., Loth, J. E., Shao, W., Sharpe, L., Alexander, J. R., Das, K., Simon, R., Fieve, R. R., Lerer, B., Endicott, J., Ott, J., Gilliam, T. C. & Baron, M. (1994). A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nature Genetics 8, 291-6.
143. Taylor, D. R., Puig, M., Darnell, M. E., Mihalik, K. & Feinstone, S. M. (2005). New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. Journal of Viorology 79, 6291-8.
144. Tojo, K., Sekijima, Y., Suzuki, T., Suzuki, N., Tomita, Y., Yoshida, K., Hashimoto, T. & Ikeda, S. (2006). Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. Movement Disorders 21, 1510-3.
145. Tomiyama, M., Rodriguez-Puertas, R., Cortes, R., Pazos, A., Palacios, J. M. & Mengod, G. (2002). Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis. Synapse 45, 245-9.
146. Toth, A. M., Li, Z., Cattaneo, R. & Samuel, C. E. (2009). RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. Journal of Biological Chemistry 284, 29350-6.
147. Valente, L. & Nishikura, K. (2007). RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. Journal of Biological Chemistry 282, 16054-61.
148. van Blitterswijk, M. & Landers, J. E. (2010). RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics 11, 275-90.
149. Veske, A., Oehlmann, R., Younus, F., Mohyuddin, A., Muller-Myhsok, B., Mehdi, S. Q. & Gal, A. (1996). Autosomal recessive non-syndromic deafness locus (DFNB8) maps on chromosome 21q22 in a large consanguineous kindred from Pakistan. Human Molecular Genetics 5, 165-8.
150. Visvader, J. E. (2011). Cells of origin in cancer. Nature 469, 314-22.
151. Vitali, P., Basyuk, E., Le Meur, E., Bertrand, E., Muscatelli, F., Cavaille, J. & Huttenhofer, A. (2005). ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. Journal of Cell Biology 169, 745-53.
152. Wahlstedt, H., Daniel, C., Enstero, M. & Ohman, M. (2009). Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Research 19, 978-86.
153. Wang, Q., Khillan, J., Gadue, P. & Nishikura, K. (2000). Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290, 1765-8.
154. Wang, Q., Miyakoda, M., Yang, W., Khillan, J., Stachura, D. L., Weiss, M. J. & Nishikura, K. (2004). Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. Journal of Biological Chemistry 279, 4952-61.
155. Wang, Y., Zeng, Y., Murray, J. M. & Nishikura, K. (1995). Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. Journal of Molecular Biology 254, 184-95.
156. Weier, H. U., George, C. X., Greulich, K. M. & Samuel, C. E. (1995). The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. Genomics 30, 372-5.
157. Whitney, N. P., Peng, H., Erdmann, N. B., Tian, C., Monaghan, D. T. & Zheng, J. C. (2008). Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons. Faseb Journal 22, 2888-900.
158. Whittington, J. & Holland, A. Neurobehavioral phenotype in Prader-Willi syndrome (2010). American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 154C, 438-47.
159. Wong, S. K., Sato, S. & Lazinski, D. W. (2003). Elevated activity of the large form of ADAR1 in vivo: very efficient RNA editing occurs in the cytoplasm. Rna 9, 586-98.
160. XuFeng, R., Boyer, M. J., Shen, H., Li, Y., Yu, H., Gao, Y., Yang, Q., Wang, Q. & Cheng, T. (2009). ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proceedings of the National Accademy of Science U S A 106, 17763-8.
161. Yang, L., Zhao, L., Gan, Z., He, Z., Xu, J., Gao, X., Wang, X., Han, W., Chen, L., Xu, T., Li, W. & Liu, Y. (2010). Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis. Faseb Journal 24, 3720-32.
162. Zhu, Y. & Parada, L. F. (2002). The molecular and genetic basis of neurological tumours. Nature Reviews Cancer 2, 616-26.